Files and links (2)
Published (Version of record)CC BY-NC V4.0, Open Access
Published (Version of record)CC BY-NC V4.0, Open
Journal article
Trimethoprim-sulfonamide: a valid antimicrobial treatment in foals?
Journal of the American Veterinary Medical Association, Vol.262(6)
06/2024
PMID: 38479105
Metrics
28 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Abstract
Trimethoprim-sulfonamide (TMPS) combinations are widely used to treat a range of infectious diseases in horses, but some equine practitioners are reluctant to use them for treatment of both neonatal and older foals. Considering the emergence of increased antimicrobial resistance, the use of protected antimicrobials commonly prescribed to foals should be avoided and alternative first-line therapy considered, where appropriate. This review examines the characteristics and pharmacokinetics of TMPS and its suitability for treatment of foals. Data regarding dosage and route of administration are reported on the basis of recent publications in foals. The review intends to share significant information about the common infections that are most likely responsive to TMPS treatment in foals and, as such, where TMPS might be considered a suitable first-line therapeutic option.
Details
- Title
- Trimethoprim-sulfonamide: a valid antimicrobial treatment in foals?
- Creators
- Kajsa Gustafsson - University of MilanBenjamin W Sykes - Southern Cross UniversityDenis Verwilghen - The University of SydneyKatrien Palmers - Equine Clinic De Morette (Asse, Belgium)Stacey Sullivan - Goulburn Valley Equine HospitalGaby van Galen - The University of Sydney
- Publication Details
- Journal of the American Veterinary Medical Association, Vol.262(6)
- Publisher
- American Veterinary Medical Association; SCHAUMBURG
- Identifiers
- 991013176704402368
- Copyright
- © The Authors.
- Academic Unit
- Faculty of Science and Engineering
- Language
- English
- Resource Type
- Journal article